GATA2 is essential for the endothelial-to-hematopoietic transition (EHT) and generation of hematopoietic stem cells (HSCs). It is poorly understood how GATA2 controls the development of human pluripotent stem cell (hPSC)-derived HS-like cells. Here, using human embryonic stem cells (hESCs) in which GATA2 overexpression was induced by doxycycline (Dox), we elucidated the dual functions of GATA2 in definitive hematopoiesis before and after the emergence of CD34 + CD45 + CD90 + CD38 -HS-like cells. Specifically, GATA2 promoted expansion of hemogenic precursors via the EHT and then helped to maintain HS-like cells in a quiescent state by regulating cell cycle. RNA sequencing showed that hPSC-derived HS-like cells were very similar to human fetal liver-derived HSCs. Our findings will help to elucidate the mechanism that controls the early stages of human definitive hematopoiesis and may help to develop a strategy to generate hPSC-derived HSCs.
INTRODUCTION
Primitive hematopoiesis initiates in the yolk sac with a transient wave of primitive erythroid progenitors; however, definitive hematopoiesis occurs via a temporally and spatially dynamic pattern (Palis et al., 1999) . The definitive hematopoiesis firstly generates erythroid with adult-type features but does not produce hematopoietic stem cells (HSCs) in the yolk sac (Böiers et al., 2013) . The second wave of definitive hematopoiesis is marked by the emergence of HSCs originated from hemogenic endothelium (HE) in the aorto-gonad-mesonephros (AGM) region of the embryo through the endothelial-to-hematopoietic transition (EHT) (Boisset et al., 2010; Ivanovs et al., 2011; Medvinsky and Dzierzak, 1996; Swiers et al., 2013; Taoudi et al., 2008) , while more pre-HSCs generated from AGM region move to the fetal liver (FL) and then acquire a mature HSC property (Rybtsov et al., 2016) . Developmental hematopoiesis has been mainly studied in mouse models, but early human hematopoiesis is poorly understood. The establishment of human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) led to the development of models that are ideal to explore early hematopoiesis in humans (Costa et al., 2012; Takahashi et al., 2007; Thomson et al., 1998; Yoder, 2014) . Several recent studies reported the development of hPSC-derived early mesodermal precursors into mature hematopoietic stem/progenitor cells (HSPCs) in vitro (Ng et al., 2016; Slukvin, 2016 (Rowe et al., 2016) . Although phenotypically similar to their adult-type counterparts in AGM, hPSC-derived HSPCs generated in vitro cannot reconstitute hematopoiesis in NOG-SCID mice (Ng et al., 2016) . Gene manipulation has been performed to enhance the HSC property of hPSC-derived HS-like cells. Overexpression of medial HOXA genes prolongs the maintenance of hESC-derived HSPCs but does not confer self-renewal in hESC-derived HSPCs (Dou et al., 2016) . A more recent study showed that hESC-derived CD34 + KDR +
CD43
À GPA -HE cells with a definitive hematopoietic potential reconstitute hematopoiesis in NOG-SCID mice when transfected with five transcription factors (HOXA9, ERG, RORA, SOX4, and MYB) (Sugimura et al., 2017) . However, this previous study did not purify HSCs in vitro. It remains challenging to generate hPSC-derived HSCs in vitro.
The transcription factor GATA2 plays a unique role in the development, maintenance, and quiescence of HSCs, particularly in the AGM. In mouse embryos, Gata2 is expressed in lateral plate mesoderm (LPM)-, AGM-, and FL-derived HSCs (Minegishi et al., 1999 (Minegishi et al., , 2003 . (legend continued on next page) 9.5 kb downstream of the Gata2 promoter ( + 9.5) in mice decreases Gata2 expression in HE in AGM, and abrogates the EHT (Gao et al., 2013) . RNA sequencing (RNA-seq) demonstrated that GATA2 and other HSC-specific genes are upregulated in human CD34 + CD45 + CD38 -(34 + 45 + 38 -) HSPCs derived from HE-5TF cells (Sugimura et al., 2017) . GATA2-knockout hESCs exhibit marked defects in the EHT and conversion into HSPCs, while specification of HE is unaffected (Kang et al., 2018) . By contrast, GATA2/eGFP + hESCs
give rise to an increased number of HSPCs . During the development of hPSCs into HSPCs in vitro, expression of GATA2 is upregulated along with the KDR + APLNR + CD34 À CD43 -early mesodermal precursors (Choi et al., 2012) . On the other hand, overexpression of GATA2 (GATA2-OE) hampers, rather than enhances, HSC activity in human cord blood (CB)-derived CD34 + HSCs by inducing cell-cycle arrest at the G0/G1 phase (Tipping et al., 2009 ). Thus, GATA2 has diverse effects on the early stages of mesodermal hematopoietic lineage specification, the EHT, and maintenance of HSCs. It is unknown how GATA2 elicits these effects and at what level GATA2 influences the cell fate decision. We previously reported an efficient coculture system with AGM-S3 cells that facilitates definitive hematopoiesis of hPSCs in vitro (Mao et al., 2016; Wang et al., 2018) . In the current study, we established hESCs in which GATA2-OE was induced by treatment with doxycycline (Dox) using a PiggyBac (PB)-based Tet-on system, and the functional role of GATA2 in the early stages of hematopoiesis was analyzed. Our data revealed that GATA2 functions at different time points to initiate, enhance, and maintain definitive hematopoiesis of hESCs by regulating the cell cycle. Specifically, GATA2 exerts dual functions by promoting the generation of definitive hematopoietic progenitors before and after the EHT 
RESULTS

Generation of an hESC Line with Inducible GATA2 Overexpression
To explore the function of GATA2 in hematopoietic fate determination, we generated H1-GFP-GATA2 hESCs (G2/ hESCs) in which exogenous expression of GATA2 was induced on treatment with Dox using a previously described PB-based Tet-on system ( Figure 1A ) (Chen et al., 2017) . In the absence of Dox, G2/hESCs expressed key stemnessspecific markers, such as SOX2, OCT4, and SSEA4 (Figure 1B) . PCR analysis verified that the coding sequence (CDS) of GATA2 was integrated into the genome of G2/hESCs ( Figure 1C ). G2/hESCs could be repeatedly passaged and retained a hESC phenotype without Dox (Figure 1D) . Western blotting and qRT-PCR showed increased expression of GATA2 in G2/hESCs and AGM-S3 cocultures (G2/hESC cocultures) with increased concentration of Dox from 0 to 4 mg/mL ( Figures 1E and 1F ). Treatment with Dox (1mg/mL) increased the percentage of GFP + cells and the mRNA expression of GATA2 in G2/hESCs from 0 to 96 h ( Figures 1D, 1G , and 1H). There were three hESC clones used for the experiments with 1, 2, and 4 copies of transgene detected by qPCR, respectively ( Figure 1I ) (Christodoulou et al., 2016) ; The three hESC clones showed increased expression of GATA2 mRNA and protein with increased copies of transgene detected by qRT-PCR and western blotting ( Figures 1I and 1J ). These results demonstrated that G2/hESCs were pluripotent and had a normal phenotype, that the CDS of GATA2 was integrated into the genome of these cells, and that treatment with Dox-induced GATA2-OE from 0 to 4 mg/mL.
GATA2 Overexpression in hESCs Promotes Definitive Hematopoiesis
We firstly elucidated the hematopoietic cells in the H1 hESCs and AGM-S3 cocultures ( Figure 2A ). KDR + cells, which are mesodermal precursors of hematopoietic and endothelial lineages, gradually express CD34 during human embryonic development (Cortés et al., 1999 ) hematopoietic progenitors in a stepwise manner (Figures S1E and S1F), as occurs in other hematopoietic systems (Slukvin, 2013) . Figure S1H ).
These data demonstrate that the AGM-S3 stromal cell line efficiently induced hematopoietic differentiation of hESCs and simulated the early stages of hematopoiesis ( Figure S1I ) (Mao et al., 2016; Wang et al., 2018 Figures S2B and S2C ).
On the other hand, the vector control hESCs showed no difference in differentiation with and without Dox ( Figure S2C ). To identify barriers to the generation of hematopoietic cells from GATA2-overexpressing hESCs, we analyzed the proportion of hematopoietic cells among G2/hESC cocultures at days 6, 10, and 14, when Dox treatment was initiated at different time points ( Figure S2D Figure S2D ).
We next evaluated the effect GATA2-OE on hematopoiesis from day 2 to 22. The increased level of GATA2 expression mainly relied on exogenous GATA2 expression both at the various times of differentiation and in the 34 + 43 + -sorted cells with Dox ( Figures S2E and S2F ). The total cell number was not markedly affected (data not shown). cultures. Total cells collected from Dox-treated cocultures on days 14, 20, and 22 formed an increased number of colonies, which coincided with the increase in hematopoietic cells; however, more colonies were observed when Dox was removed during the colony-formation assay ( Figure 2C ). BFU-E and Mix colonies recovered when Dox was removed in cloned cultures ( Figure 2D ). Figure 2G ).These data demonstrate that GATA2-OE promotes the generation of hematopoietic cells and prolongs the colony-forming unit (CFU) potential of cocultured cells. Figure 3G ).
GATA2 Overexpression Promotes Definitive Hematopoiesis via Differentiation of hESC-Derived
To further elucidate the effect of GATA2-OE on EHT, cocultures on day 4, which lacked emerging CD43 + cells,
were transfected with GATA2-targeting (si-GATA2: GUCC AAGAAGAGCAAGAAATT) or control siRNA (si-N:UUCU CCGAACGUGUCACGUTT) ( Figure S3C ). Transfection of 20 nM si-GATA2 significantly decreased endogenous GATA2 expression by more than 42.3% ( Figure 3H ). Figure 4G ).
Removal of Dox increased the numbers of BFU-E, Mix, GM, and M colonies, while GATA2-OE increased the number of G colonies ( Figures 4H and 4I ). More CD71 + GPA + erythroid cells were detected by FACS analysis when Dox was removed during the colony-formation assay ( Figure S4B ). BFU-E formed from GATA2-overexpressing cocultured cells generated erythroid cells that predominantly expressed adult b-globin ( Figure 4J ). These data demonstrate that GATA2-OE inhibits the differentiation of hematopoietic cells. and CYB1P1 increased ( Figure 5G ). Enforced GATA-2 expression showed no increase in apoptosis of coculture cells. GATA2-OE inhibited apoptosis in CD34 high CD45 + cells on coculture day14 ( Figure 5H ). These data suggest that GATA2-OE prevents the expansion and differentiation of 34 + 45 + cells isolated from cocultures on day 14 by inducing quiescence and inhibiting apoptosis. Figure 6A ). A two-step differentiation protocol was applied to develop HS-like cells from H1 hESC cocultures on day14 ( Figure 6B ). Medium was replaced by a-minimum essential medium containing 20% FBS, thrombopoietin, stem cell factor, and FMS-like tyrosine kinase 3 ligand (FL), which supports the maintenance of multipotent human HS-like cells ( Figure 6B) Figure 7A ). 
GATA2 Overexpression Selectively Promotes the
38
+ cells derived from untreated and Dox-treated G2/hESC cocultures on day 14 in medium containing FBS and cytokines. Error bars represent mean ± SD of samples from at least three independent experiments. NS, not significant; *p < 0.05, **p < 0.01. Figures 7C and 7D ). Repressed genes in G2-OE 90 + cells were mostly enriched in gene ontology categories related to cell adhesion, motility, migration, proliferation, and differentiation ( Figure 7E ). Kyoto Encyclopedia of Genes and Genome (KEGG) analysis suggestd that several pathways important for regulation of HSCs were downregulated in G2-OE 90 + cells (Figure 7F) . Gene set enrichment analysis (GSEA) showed that the stem cell proliferation and differentiation genes were repressed in G2-OE 90 + cells (Figures 7G and S6B ).
GSEA showed that the positive regulation of mitotic cellcycle and apoptosis genes were repressed in G2-OE 90 + cells
( Figures 7H and S6C ). Expression of genes related to the AHR signaling pathway, which was previously reported to be inhibited by SR1 (Rentas et al., 2016) , was also inhibited in G2-OE 90 + cells ( Figure S6D ).
DISCUSSION
The mechanism that controls the development and maturation of hPSC-derived HSCs during definitive hematopoiesis remains to be elucidated, and its characterization is hindered by the lack of a serial observation method. GATA2 is expressed in a spatial-and temporal-dependent manner during definitive hematopoiesis and is thus a good marker to monitor early hematopoiesis of hPSCs. Using a PB-based Tet-on system to monitor GATA2-OE at different stages of hematopoiesis, we found that GATA2 plays dual roles before and after the emergence of 34 + 43 + 45 + HSPCs during definitive hematopoiesis. Lugus et al. (2007) reported that GATA2-OE promotes the generation of mesodermal cells from mouse embryonic stem cells. Forced expression of GATA2 stimulates hematopoietic specification at the mesodermal stage in a cellautonomous manner in Xenopus (Maeno et al., 1996) . However, knockout of GATA2 in hESCs does not markedly affect specification of mesodermal and endothelial lineages before hematopoiesis (Kang et al., 2018) .
In our coculture system, GATA2-OE enhanced the generation of K + 34 À cells, which further developed into K + 34 + hemogenic cells, suggesting GATA2 may promote early mesoderm differentiation toward endothelium and hematopoiesis. The discrepancy in the effects of GATA2 knockout and our overexpression system in mesodermal development might be because of the differentiation conditions used, the transient nature of K + 34 À mesodermal cells, and the level of GATA2. A culture system favoring mesoderm differentiation will be more suitable for clarifying it. Analysis of definitive hematopoiesis in the AGM region in conditional GATA2-knockout mice demonstrated that GATA2 is essential for the EHT (de Pater et al., 2013; Gao et al., 2013) . The EHT is markedly inhibited in GATA2 À/À hESCs, and this effect is rescued by GATA2 overexpression (Kang et al., 2018) RUNX1c marked a subset of cells expressing CD34, a cell surface marker present on human AGM-derived HSCs (Ivanovs et al., 2014) . RUNX1c tracked EHT in the hematopoiesis of hESCs, while transcription factor GATA2, GATA1, and SPI1 abundantly expressed in RUNX1c + cells compared with RUNX1c À cells (Ng et al., 2016) . Thus, our data suggest that GATA2-OE enhances definitive hematopoiesis through the promotion of EHT with a conserved cooperation of these critical genes for definitive hematopoiesis. (Cesana et al., 2018) . (Hirasawa et al., 2002; Huang et al., 2016; Tsai et al., 1994) . Besides, GATA2-OE promotes quiescence in human CB-HSCs, sacrificing their proliferation and performance in long-term culture-initiating cell assays (Tipping et al., 2009) . Enforced expression of GATA2 also blocks proliferation and differentiation of murine BM cells (Persons et al., 1999) . GATA2 seems to elicit a critical dose-dependent effect on maintenance of HSCs during early and late hematopoiesis. A recent study demonstrated that pulsatile changes in GATA2 expression subtly regulated the generation of HSCs (Eich et al., 2017 (Slukvin, 2013) . Recent studies showed that hESC-derived hematopoietic cells are very similar to human AGM-and FLderived HSCs in terms of their gene profiles and immunophenotypes, and thus these cells are defined as HS-like cells (Dou et al., 2016; Ng et al., 2016 strated that the maintenance of hESC-derived HS-like cells on GATA2-OE was due to downregulation of stem cell proliferation, differentiation, cell-cycle, and apoptosis pathways. Phosphatidylinositol 3-kinase-Akt signaling, which maintains the properties of HSCs, were downregulated on GATA2-OE (Juntilla et al., 2010) . AHR antagonists such as SR1 promoted the expansion of human HSCs (Boitano et al., 2010) . The downregulation of genes related to the AHR pathway in G2-OE 90 + cells suggests that GATA2
maintains HS-like cells by inhibiting AHR signaling. AGM-derived stromal cells were reported to predominantly support definitive hematopoiesis of hESCs (Ledran et al., 2008) . AGM-S3 cells induce maturation of immature embryonic yolk sac cells and para-aortic splanchnopleure cells into reconstituting HSCs (Matsuoka et al., 2001 However, we failed to detect long-term engraftment of these cells in immunodeficient mice (data not shown), suggesting that intrinsic maturity and exogenous factors are further required for gaining transplantable ability in hESC-derived HS-like cells. We provide evidence that complex and subtle regulation of GATA2 is important for the development, expansion, and maintenance of hESC-derived HS-like cells. GATA2 plays two functionally distinct roles in the generation and expansion of HSCs in the AGM region and the proliferation of HSCs in adult BM in mice (Ling et al., 2004 
EXPERIMENTAL PROCEDURES
Maintenance of hESCs H1 hESCs were provided by Professor Tao Cheng and maintained on Matrigel-coated plates in mTeSR1 medium (STEMCELL Technologies). The cells were dissociated into clumps using ReLeSR (STEMCELL Technologies) every 4-5 days.
Establishment of G2/hESCs
H1 hESCs were seeded into a 24-well plate with 70%-90% confluent at the time of transfection. Plasmid DNA-lipid complexes (containing 0.5 mg of the PB-Tet-on-GFP-T2A-hGATA2 vector, and 0.5 mg of PB200PA vector containing catalytic component) were added to the cells per well and incubated for 2-4 days according to the manufacturer's description of lipofectamine 3000 (Invitrogen). Transfected cells were selected by culture in medium containing 1 mg/mL puromycin (Sigma). For single-cell culture, cells were dissociated into single cells with Accutase (Gibco) and maintained in mTeSR1 medium supplemented with Y27632 (Cayman). Puromycin-resistant clones were picked, and successful targeting was confirmed by western blotting, qRT-PCR (F1:5 0 -CAGCAAGGCTCGTTCCTGTTCA-3 0 , R1:5 0 -ATGAGT GGTCGGTTCTGCCCAT-3 0 ) and PCR (F2: 5 0 GAGGAAGTCTTC TAACATGCGGT-3 0 , R2: 5 0 CCCTTCGTCTGACGTGGCAG-3 0 ). To minimize variation owing to long-term selection, multiple stable cell lines were used and all experiments were repeated at least three times. The study was approved by the Ethics Committee of the Institute of Blood Transfusion, CAMS & PUMC.
Coculture of hESCs and AGM-S3 Cells
Approximately 50-60 clumps of hESCs, each of which contained 3-4 3 10 2 cells, were seeded onto 2-3 310 5 irradiated AGM-S3 cells in each well of a 6-well plate and cultured in hPSC maintenance medium. hESCs were differentiated into HSPCs as described previously (Mao et al., 2016) . The medium was changed every day.
Colony Assay
Hematopoietic potential of cells was assessed by culture on methylcellulose (H4320, STEMCELL Technologies) supplemented with 1% penicillin/streptomycin (Invitrogen) and cytokines, which were described previously (Ma et al., 2008) . BFU-E, CFUMix, CFU-GM, CFU-G, and CFU-M colonies were assessed after 10-16 days.
Flow Cytometry and Cell Sorting
Cocultured cells were dissociated with 0.25% trypsin-EDTA solution (Invitrogen) and filtered through a 70-mm nylon mesh to obtain a single-cell suspension. Flow cytometry was performed using a FACSCanto II system (BD Biosciences), and data were analyzed using FlowJo software (v.10.0.8.). Cell sorting was performed using a MoFlo Astrios High Speed Cell Sorter (Beckman Coulter). The antibodies used are presented in Table S1 .
Cell-Cycle Analysis
Cells were treated with BrdU for 6 h, stained for surface antigens, and processed using an APC-BrdU Flow Kit (BD) according to the manufacturer's instructions.
Apoptosis Assays
Cells were detected by flow cytometry of cells stained according to the manufacturer's instructions with annexin V-APC and 7-AAD (BioLegend).
Statistical Analysis
All data are presented as the mean ± SD. Statistical analyses were performed using the Student's t test. p < 0.05 was considered significant.
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